<DOC>
	<DOCNO>NCT00508378</DOCNO>
	<brief_summary>Primary Objectives : 1 . To assess preference woman ovarian cancer , clinical caregiver , familial caregiver , control group toxicity associate chemotherapy . - To compare preference woman ovarian cancer preference clinical caregiver . - To compare preference woman ovarian cancer preference familial caregiver . - To compare preference woman ovarian cancer preference woman control group . 2 . To prospectively collect quality life data woman ovarian cancer . 3 . To prospectively collect symptom assessment data woman ovarian cancer .</brief_summary>
	<brief_title>Chemotherapy-Related Toxicities In Ovarian Cancer Patients</brief_title>
	<detailed_description>Patients study recruit Gynecologic Oncology Clinic wait area . All participant ( patient , family clinical caregiver , control group woman cancer ) study take part interview see feel different side-effects chemotherapy . The interview involve read short description side-effects answer question ask opinion . The actual interview take 30-45 minute complete . The interview either take place private conference room clinic private room Ambulatory Treatment Center ( ATC ) . Patients also give quality life symptom assessment questionnaire . The questionnaire simple read quick answer . The questionnaire take 15 minute complete . The participant 's involvement study limit questionnaire/interview . Once do , participant finish study . This investigational study . A total 288 people take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>1 . Women epithelial ovarian cancer present UTMDACC Gynecologic Oncology Clinic currently undergo chemotherapy 2 . Women history epithelial ovarian cancer present UTMDACC Gynecologic Oncology Clinic see followup 3 . Women least 18 year age 4 . Women speak English 5 . Clinical caregiver patient ovarian cancer ( UTMDACC gynecologic oncologist , UTMDACC gynecologic medical oncologist , UTMDACC register nurse license vocational nurse UTMDACC Gynecology Clinic , UTMDACC gynecologic oncology fellow resident ) 6 . Familial caregiver patient ovarian cancer ( primary caregiver ) 1 . Participants nonEnglish speaker 2 . Participants le 18 year age</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Chemotherapy Side-Effects</keyword>
	<keyword>Interview</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Caregivers</keyword>
</DOC>